Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Deep Vein Thrombosis (DVT) - Overview
Deep Vein Thrombosis (DVT) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Deep Vein Thrombosis (DVT) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Deep Vein Thrombosis (DVT) - Companies Involved in Therapeutics Development
Bio-Synectics Inc
CarboMimetics
Chengdu Easton Biopharmaceuticals Co Ltd
Glycan Therapeutics Inc
Kolmar Korea Co Ltd
Laboratorios Farmaceuticos Rovi SA
Marizyme Inc
Protheragen Inc
Tianjin Pharmaceuticals Group Co Ltd
Deep Vein Thrombosis (DVT) - Drug Profiles
BS-112 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CM-20201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CX-3002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
enoxaparin sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KKM-183A - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MB-104 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Polysaccharide to Inhibit Coagulation Factor X for Deep Vein Thrombosis and Sickle Cell Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit NMMHC IIA for Deep Vein Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Zifa-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Deep Vein Thrombosis (DVT) - Dormant Projects
Deep Vein Thrombosis (DVT) - Discontinued Products
Deep Vein Thrombosis (DVT) - Product Development Milestones
Featured News & Press Releases
Sep 19, 2018: ROVI has commenced the marketing of its enoxaparin biosimilar in Spain
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Deep Vein Thrombosis (DVT), 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Deep Vein Thrombosis (DVT), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Bio-Synectics Inc, 2021
Deep Vein Thrombosis (DVT) - Pipeline by CarboMimetics, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Chengdu Easton Biopharmaceuticals Co Ltd, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Glycan Therapeutics Inc, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Kolmar Korea Co Ltd, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Laboratorios Farmaceuticos Rovi SA, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Marizyme Inc, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Protheragen Inc, 2021
Deep Vein Thrombosis (DVT) - Pipeline by Tianjin Pharmaceuticals Group Co Ltd, 2021
Deep Vein Thrombosis (DVT) - Dormant Projects, 2021
Deep Vein Thrombosis (DVT) - Dormant Projects, 2021 (Contd..1)
Deep Vein Thrombosis (DVT) - Discontinued Products, 2021